Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Mosna

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancers|July 13, 2024
The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of ViewFederico Mosna
Stem Cells International|February 17, 2016
Stem Cell Modeling of Core Binding Factor Acute Myeloid LeukemiaFederico Mosna, Michele Gottardi
Journal of Clinical Medicine|June 8, 2017
Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?Federico Mosna, Debora Capelli, Michele Gottardi
Stem Cells and Development|May 22, 2010
Human bone marrow and adipose tissue mesenchymal stem cells: a user's guideFederico Mosna, Luc Sensebé, Mauro Krampera
Cancers|October 29, 2025
Allogeneic Hematopoietic Stem Cell Transplantation as a Platform to Treat Chemorefractory Acute Myeloid Leukemia in Adult PatientsDaniel Alzetta, Irene M Cavattoni, Federico Mosna
Cardiovascular & Hematological Agents in Medicinal Chemistry|June 16, 2010
Cell therapy for cardiac regeneration after myocardial infarct: which cell is the best?Federico Mosna, Francesco Annunziato, Giovanni Pizzolo, et al.
Haematologica|November 4, 2005
Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapyDino Veneri, Achille Ambrosetti, Massimo Franchini, et al.
Leukemia & Lymphoma|October 6, 2012
The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center seriesCristina Tecchio, Federico Mosna, Angelo Andreini, et al.
Stem Cells (Dayton, Ohio)|May 13, 2011
Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophilsMarco A Cassatella, Federico Mosna, Alessandra Micheletti, et al.
European Journal of Haematology|May 21, 2011
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemiaCristina Tecchio, Ilaria Nichele, Federico Mosna, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancers|July 13, 2024
The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of ViewFederico Mosna
Stem Cells International|February 17, 2016
Stem Cell Modeling of Core Binding Factor Acute Myeloid LeukemiaFederico Mosna, Michele Gottardi
Journal of Clinical Medicine|June 8, 2017
Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?Federico Mosna, Debora Capelli, Michele Gottardi
Stem Cells and Development|May 22, 2010
Human bone marrow and adipose tissue mesenchymal stem cells: a user's guideFederico Mosna, Luc Sensebé, Mauro Krampera
Cancers|October 29, 2025
Allogeneic Hematopoietic Stem Cell Transplantation as a Platform to Treat Chemorefractory Acute Myeloid Leukemia in Adult PatientsDaniel Alzetta, Irene M Cavattoni, Federico Mosna
Cardiovascular & Hematological Agents in Medicinal Chemistry|June 16, 2010
Cell therapy for cardiac regeneration after myocardial infarct: which cell is the best?Federico Mosna, Francesco Annunziato, Giovanni Pizzolo, et al.
Haematologica|November 4, 2005
Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapyDino Veneri, Achille Ambrosetti, Massimo Franchini, et al.
Leukemia & Lymphoma|October 6, 2012
The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center seriesCristina Tecchio, Federico Mosna, Angelo Andreini, et al.
Stem Cells (Dayton, Ohio)|May 13, 2011
Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophilsMarco A Cassatella, Federico Mosna, Alessandra Micheletti, et al.
European Journal of Haematology|May 21, 2011
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemiaCristina Tecchio, Ilaria Nichele, Federico Mosna, et al.
Pageof 4